481 An affinity-optimized CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade

Xavier Chauchet; Sebastien Calloud; Margaux Legrand; Laura Cons; Laurence Chatel; Adeline Lesnier; Nicolas Bosson; Pauline Lloveras; Pauline Malinge; Ulla Ravn; Valery Moine; Bruno Daubeuf; Yves Poitevin; Giovanni Magistrelli; Susana Salgado-Pires; Dmitry Shchelokov; Oleg Demin; Limin Shang; Krzysztof Masternak; Walter Ferlin

doi:10.1136/jitc-2022-SITC2022.0481

Article info

PDF

Regular and Young Investigator Award Abstracts

Checkpoint Blockade Therapy

481 An affinity-optimized CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade

Free

Authors

Xavier Chauchet Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Sebastien Calloud Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Margaux Legrand Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Laura Cons Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Laurence Chatel Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Adeline Lesnier Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Nicolas Bosson Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Pauline Lloveras Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Pauline Malinge Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Ulla Ravn Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Valery Moine Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Bruno Daubeuf Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Yves Poitevin Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Giovanni Magistrelli Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Susana Salgado-Pires Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Dmitry Shchelokov InsysBio UK Ltd, Edinburgh, UK PubMed articles Google scholar articles
Oleg Demin InsysBio UK Ltd, Edinburgh, UK PubMed articles Google scholar articles
Limin Shang Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Krzysztof Masternak Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles
Walter Ferlin Light Chain Bioscience-Novimmune SA, Geneva, Switzerland PubMed articles Google scholar articles

Citation

Chauchet X, Calloud S, Legrand M, et al

481 An affinity-optimized CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0481

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password